Clinical Trial Update: Efficacy of TR 987, Beta-1,3-1,6-D-glucan, in the Treatment of Chronic Venous Insufficiency Ulcers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating TR 987 (Beta-1,3-1,6-D-glucan) for treatment of chronic venous insufficiency ulcers (venous leg ulcers) is currently ACTIVE_NOT_RECRUIT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Insufficiency
• Venous Leg Ulcer

Drugs mentioned

• TR-987

Snippet

Sponsor: SerenaGroup, Inc. | Conditions: Venous Leg Ulcer | Phase 2 | Status: ACTIVE_NOT_RECRUITING